Mathieu Blery

Person

Marseilles, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment regimens using anti-NKG2A antibodies
- Patent number 12,037,392
- Issue date Jul 16, 2024
- Innate Pharma
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of peripheral T cell lymphoma
- Patent number 11,999,784
- Issue date Jun 4, 2024
- Innate Pharma
- Cécile Bonnafous
- G01 - MEASURING TESTING
Information Patent Grant
Neutralization of inhibitory pathways in lymphocytes
- Patent number 11,572,410
- Issue date Feb 7, 2023
- Innate Pharma
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NKp46 binding agents
- Patent number 11,377,492
- Issue date Jul 5, 2022
- Innate Pharma
- Nadia Anceriz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancers using anti-NKG2A agents
- Patent number 11,225,519
- Issue date Jan 18, 2022
- Innate Pharma
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neutralization of inhibitory pathways in lymphocytes
- Patent number 10,870,700
- Issue date Dec 22, 2020
- Innate Pharma
- Pascale Andre
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neutralization of inhibitory pathways in lymphocytes
- Patent number 10,711,063
- Issue date Jul 14, 2020
- Innate Pharma
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment regimens using anti-NKG2A antibodies
- Patent number 10,676,523
- Issue date Jun 9, 2020
- Innate Pharma
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mica binding agents
- Patent number 10,577,416
- Issue date Mar 3, 2020
- Innate Pharma, S.A.
- Mathieu Blery
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination of anti-KIR and anti-CS1 antibodies to treat multiple m...
- Patent number 10,494,433
- Issue date Dec 3, 2019
- Bristol-Myers Squibb Company
- Pascale Andre
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of peripheral T cell lymphoma
- Patent number 10,344,087
- Issue date Jul 9, 2019
- Innate Pharma
- Cécile Bonnafous
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of cancers using anti-NKG2A agents
- Patent number 10,329,348
- Issue date Jun 25, 2019
- Innate Pharma
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for treating proliferative disorders
- Patent number 9,447,185
- Issue date Sep 20, 2016
- Innate Pharma, S.A.
- Francois Romagne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF PERIPHERAL T CELL LYMPHOMA
- Publication number 20240425586
- Publication date Dec 26, 2024
- Innate Pharma
- CÉCILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES
- Publication number 20240368281
- Publication date Nov 7, 2024
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20230303691
- Publication date Sep 28, 2023
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20230235060
- Publication date Jul 27, 2023
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NKp46 BINDING AGENTS
- Publication number 20220340661
- Publication date Oct 27, 2022
- Innate Pharma
- NADIA ANCERIZ
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES
- Publication number 20210238285
- Publication date Aug 5, 2021
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20210122821
- Publication date Apr 29, 2021
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20200332008
- Publication date Oct 22, 2020
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES
- Publication number 20200299383
- Publication date Sep 24, 2020
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY ANTIBODY DRUG CONJUGATES BINDING TO A HUMAN MICA P...
- Publication number 20200023071
- Publication date Jan 23, 2020
- Innate Pharma
- MATHIEU BLERY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NKp46 BINDING AGENTS
- Publication number 20190367609
- Publication date Dec 5, 2019
- Innate Pharma
- NADIA ANCERIZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCERS USING ANTI-NKG2A AGENTS
- Publication number 20190322744
- Publication date Oct 24, 2019
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF PERIPHERAL T CELL LYMPHOMA
- Publication number 20190315857
- Publication date Oct 17, 2019
- Innate Pharma
- CÉCILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20190031755
- Publication date Jan 31, 2019
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCERS USING ANTI-NKG2A AGENTS
- Publication number 20170313773
- Publication date Nov 2, 2017
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES
- Publication number 20170298131
- Publication date Oct 19, 2017
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20170291947
- Publication date Oct 12, 2017
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-MICA ANTIBODIES
- Publication number 20170267764
- Publication date Sep 21, 2017
- Innate Pharma
- MATHIEU BLERY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION OF ANTI-KIR AND ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE M...
- Publication number 20160257750
- Publication date Sep 8, 2016
- Bristol-Myers Squibb Company
- Pascale ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF PERIPHERAL T CELL LYMPHOMA
- Publication number 20150376274
- Publication date Dec 31, 2015
- Innate Pharma
- CÉCILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
MICA BINDING AGENTS
- Publication number 20150191542
- Publication date Jul 9, 2015
- Innate Pharma, S.A.
- Mathieu Blery
- G01 - MEASURING TESTING
Information Patent Application
Compositions and Methods for Treating Proliferative Disorders
- Publication number 20080274047
- Publication date Nov 6, 2008
- Innate Pharma
- Francois Romagne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Expression Vectors and Methods for Obtaining Nk Cell Specific Expre...
- Publication number 20080196111
- Publication date Aug 14, 2008
- Innate Pharma S.A.
- Eric Vivier
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING

Mathieu Blery

Person

Patents Grantslast 30 patents

Treatment regimens using anti-NKG2A antibodies

Treatment of peripheral T cell lymphoma

Neutralization of inhibitory pathways in lymphocytes

NKp46 binding agents

Treatment of cancers using anti-NKG2A agents

Neutralization of inhibitory pathways in lymphocytes

Neutralization of inhibitory pathways in lymphocytes

Treatment regimens using anti-NKG2A antibodies

Mica binding agents

Combination of anti-KIR and anti-CS1 antibodies to treat multiple m...

Treatment of peripheral T cell lymphoma

Treatment of cancers using anti-NKG2A agents

Compositions and methods for treating proliferative disorders

Patents Applicationslast 30 patents

TREATMENT OF PERIPHERAL T CELL LYMPHOMA

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

NKp46 BINDING AGENTS

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

IMMUNOMODULATORY ANTIBODY DRUG CONJUGATES BINDING TO A HUMAN MICA P...

NKp46 BINDING AGENTS

TREATMENT OF CANCERS USING ANTI-NKG2A AGENTS

TREATMENT OF PERIPHERAL T CELL LYMPHOMA

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

TREATMENT OF CANCERS USING ANTI-NKG2A AGENTS

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

ANTI-MICA ANTIBODIES

COMBINATION OF ANTI-KIR AND ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE M...

TREATMENT OF PERIPHERAL T CELL LYMPHOMA

MICA BINDING AGENTS

Compositions and Methods for Treating Proliferative Disorders

Expression Vectors and Methods for Obtaining Nk Cell Specific Expre...